Section 32

AI × Biotech Thesis

Bill Maris's (ex-GV founder) second fund focused on frontier tech-bio convergence. Strong AI platform thesis.

• Absci
• Generate:Biomedicines (co-investor)
• Profluent Bio

· Dot indicates company has a profile page on biotech.today

• Bill Maris

  Founder & Managing Partner

Frequent Co-Investors

• ARCH Venture Partners2 shared · Absci, Generate:Biomedicines (co-investor)
• Atlas Venture1 shared · Generate:Biomedicines (co-investor)
• Catalio Capital Management1 shared · Absci
• DCVC Bio1 shared · Profluent Bio
• OrbiMed1 shared · Absci